Guided Therapeutics Inc

OTC: GTHP    
Share price (5/2/24): $0.09    
Market cap (5/2/24): $4.856 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 10-Q 1 page Promissory Note
12/34/56
EX-10.2
from 10-Q 1 page Promissory Note
12/34/56
EX-10.1
from 10-Q 5 pages Guided Therapeutics, Inc. (The “Company”) Is Pleased to Offer to You the Opportunity to Exchange All of the Common Stock Purchase Warrants of the Company Issued as Commission Warrants (The “Exchange Warrants”) Currently Held by You (The “Holder”) in Shares of Common Stock. Capitalized Terms Not Otherwise Defined Herein Shall Have the Meanings Set Forth in the Common Stock Purchase Warrant Agreement, Pursuant to the Date of Issuance, Between the Company and the Purchasers Signatory Thereto Pursuant to Which the Company Issued the Exchange Warrants
12/34/56
EX-10.6
from 10-Q 2 pages Amendment #1 to Exchange Agreement
12/34/56
EX-10.4
from 8-K 16 pages Common Stock Purchase Warrant Guided Therapeutics, Inc
12/34/56
EX-10.3
from 8-K 16 pages Common Stock Purchase Warrant Guided Therapeutics, Inc
12/34/56
EX-10.2
from 8-K 14 pages Exchange Agreement
12/34/56
EX-10.1
from 8-K 33 pages Securities Purchase Agreement
12/34/56
EX-10.61
from S-1/A 5 pages Exchange Agreement
12/34/56
EX-10.88
from 10-K 1 page Guided Thereapeutics, Inc
12/34/56
EX-10.87
from 10-K 26 pages Exchange Agreement
12/34/56
EX-10.86
from 10-K 1 page Promissory Note Per Exchange Agreement Dated July 9, 2020
12/34/56
EX-10.85
from 10-K 4 pages Series D Preferred Stock Financing Group Warrant Exchange and Exercise Agreement Dolores Maloof
12/34/56
EX-10.84
from 10-K 4 pages December 30 2019 Equity for Debt Exchange Group Warrant Exchange and Exercise Agreement Bryan Mamula
12/34/56
EX-10.83
from 10-K 5 pages December 30 2019 Equity for Debt Exchange Group Warrant Exchange and Exercise Agreement Michael C. James
12/34/56
EX-10.82
from 10-K 4 pages Warrant Exchange Agreement
12/34/56
EX-10.81
from 10-K 4 pages December 30 2019 Equity for Debt Exchange Group Warrant Exchange and Exercise Agreement Flynn D. Case Living Trust
12/34/56
EX-10.80
from 10-K 6 pages Series D Preferred Stock Financing Group Warrant Exchange and Exercise Agreement Mark L. Faupel
12/34/56
EX-10.79
from 10-K 6 pages Series D Preferred Stock Financing Group Warrant Exchange and Exercise Agreement Gene S. Cartwright
12/34/56
EX-10.78
from 10-K 6 pages December 30 2019 Equity for Debt Exchange Group Warrant Exchange and Exercise Agreement K2 Medical, LLC
12/34/56